Biosante Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biosante Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $33M | 555k | 59.66 |
| 2024-06-30 | $14M | 214k | 63.68 |
| 2024-03-31 | $16M | 232k | 69.13 |
| 2023-12-31 | $12M | 224k | 55.14 |
| 2023-09-30 | $5.4M | 94k | 58.06 |
| 2023-06-30 | $4.9M | 91k | 53.83 |
| 2023-03-31 | $1.3M | 34k | 39.39 |
| 2022-12-31 | $1.6M | 39k | 40.30 |
| 2022-06-30 | $1.1M | 35k | 29.67 |
| 2022-03-31 | $804k | 28k | 28.37 |
| 2021-12-31 | $1.5M | 32k | 46.00 |
| 2021-03-31 | $2.1M | 59k | 36.14 |
| 2020-12-31 | $1.6M | 54k | 29.05 |
| 2020-09-30 | $215k | 7.6k | 28.22 |
| 2020-06-30 | $187k | 6.7k | 27.78 |
| 2020-03-31 | $287k | 6.8k | 42.25 |
| 2019-12-31 | $436k | 7.1k | 61.66 |
| 2019-09-30 | $5.2M | 71k | 72.74 |
| 2019-06-30 | $1.2M | 15k | 79.65 |
| 2019-03-31 | $315k | 4.4k | 70.92 |
| 2018-12-31 | $2.8M | 62k | 45.10 |
| 2018-09-30 | $3.8M | 68k | 56.76 |
| 2018-06-30 | $2.4M | 35k | 67.09 |
| 2018-03-31 | $1.8M | 31k | 58.82 |
| 2017-12-31 | $3.5M | 53k | 64.70 |
| 2017-06-30 | $504k | 11k | 46.51 |
| 2017-03-31 | $598k | 12k | 48.34 |
| 2016-12-31 | $1.6M | 26k | 61.22 |
| 2016-09-30 | $699k | 11k | 66.36 |
| 2016-06-30 | $296k | 7.1k | 41.67 |
| 2016-03-31 | $55k | 884 | 62.50 |